R-01 Cells are treated as engineerable therapeutic chassis that can be expanded, programmed, and deployed with reproducible function.
Fang Lab At Zhejiang University
The Fang Laboratory develops programmable living therapeutic systems by combining cell engineering, immune modulation, and biomaterial design for translational medicine.
By prioritizing engineerable and reproducible cellular platforms, we seek to establish a foundation for cell-based therapies that are both biologically effective and practically scalable.
R-01 Cells are treated as engineerable therapeutic chassis that can be expanded, programmed, and deployed with reproducible function.
R-02 Therapeutic systems are designed to present ligands, secrete factors, and reshape disease biology through controlled interactions.
R-03 Materials serve as enabling interfaces that improve localization, persistence, protection, and performance in vivo.
Our work spans cell engineering, immune modulation, and biomaterial-enabled therapeutic systems for translational medicine.
Browse all publications →We welcome applicants across training stages, from undergraduate researchers to postdocs, who want to build rigorous research experience in cell engineering, immunology, biomaterials, and translational therapeutic systems.